D-Serine

N/A

Report date: 2026/04/30 20:00:20
NME

Base Information

Drug NameD-Serine
Drug Alias NameD SerineD-serine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor agonists
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsSchizophreniaPsychotic Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwanIsrael +[4
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsN/A
Inactive IndicationsSchizophreniaPsychotic Disorders

Other Information

ATC CodeN/A